BI-69A11-mediated inhibition of AKT leads to effective regression of xenograft melanoma

Supriya Gaitonde, Surya K. De, Marianna Tcherpakov, Antimone Dewing, Hongbin Yuan, Megan Riel-Mehan, Stan Krajewski, Gavin Robertson, Maurizio Pellecchia, Ze'Ev Ronai

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'BI-69A11-mediated inhibition of AKT leads to effective regression of xenograft melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds